Overview
NeuroEne Therapeutics is an Israeli startup developing endocannabinoid-based CNS modulators for treatment-resistant epilepsy and neuropathic pain, leveraging proprietary lipid nanoparticle delivery technology.
More in Neuropharmaceuticals
Latest industry news
ReVision Implant Secures โฌ4 Million to Advance Next-Generation Visual Neuroprosthetics
2026-07-25 ยท Funding
Flourish Emerges from Stealth with Bezos and Google Ventures Backing to Advance Neuroscience Therapeutics
2026-07-24 ยท Funding
Science Corp. Launches Prima BCI Implant in Europe, Bringing Vision Restoration to a New Market
2026-07-23 ยท Product
First Able-Bodied Individuals Receive Brain-Computer Implants in Landmark Expansion of BCI Eligibility
2026-07-22 ยท Research
Company details
Category
๐ Neuropharmaceuticals
Location
Tel Aviv, Israel
Funding
Seed ยท $6M
Website
www.neuroene.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages โ